ImPACT Quick Test 2
ImPACT Quick Test 2 is a cognitive assessment software (FDA Class II; FDA product code POM, Computerized Cognitive Assessment Aid For Concussion) made by ImPACT Applications, Inc., cleared under FDA 510(k) K170551 on 21 Jun 2017 and listed in FDA GUDID since 5 Mar 2021 (UDI-DI 00864127000356), active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number00864127000356 | Date5 Mar 2021 | StatusListed |
| United States | FDA 510(k)SESE | NumberK170551 | Date21 Jun 2017 | StatusActive |
Official records
- AccessGUDID record 00864127000356
- FDA 510(k) database K170551
From the FDA record
- Device description
- ImPACT Quick Test is intended for use as a computerized cognitive test to aid in the assessment of concussion in individuals ages 12-70
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- FDA 510(k) K170551 decided 21 Jun 2017 Active
- FDA GUDID UDI-DI 00864127000356 listed 5 Mar 2021 Listed
Timeline
- Cleared FDA 510(k) K170551
- Listed FDA GUDID 00864127000356
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- Trade name
- ImPACT Quick Test
- Generic name
- Cognitive assessment software
- Model / reference
- 2
- Primary DI / UDI-DI
- 00864127000356
- 510(k) Number
- FDA product code
- POM
- GMDN term
- Cognitive assessment software
- Device class
- Class II
- Regulation number
- 882.1471
- GUDID distribution status
- In Commercial Distribution
Similar devices
Other devices filed under FDA product code POM (Computerized Cognitive Assessment Aid For Concussion).